Maternal outcome in accreta cases. Conservative surgery and hysterectomy in Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, from January 2017 to January 2018
Downloads
HIGHLIGHT
1. As the incidence of placenta accreta is increasing which seems to parallel the increasing cesarean delivery rate, advance planning should be made for the management of delivery.
2. Maternal outcome of placenta accreta cases in a national hospital was reported based on the surgical technique performed.
3. No significant results of maternal outcome undergoing conservative surgery and conventional hysterectomy in managing accreta cases in the national hospital.
ABSTRACT
Objectives: To report maternal outcome based on surgical technique on the management of accreta. The study was conducted in Cipto Mangunkusumo Hospital, Jakarta, Indonesia from January 2017 to January 2018.
Case Report: There were 1609 cases of pregnant women delivered during the study period. From these, the prevalence of previous caesarean section was 73 cases, including 20 cases of accreta. Total maternal mortality for 1 year in Cipto Mangunkusumo Hospital, Jakarta, Indonesia, was 11, and accreta contributed 3 cases. We reported 20 cases of accreta in pregnancy The maternal outcomes, including bladder injury, duration of operation, intraoperative bleeding, length of hospitalization, and mortality, were evaluated. From 20 cases, 8 patients had one previous caesarean history, 11 had second previous caesarean section, while 2 patient had third previous caesarean section history. Of women with placenta accreta, about 7 patients (35%) had delivery in fullterm pregnancies, while 13 (65%) had delivery in preterm pregnancy. Surgical technique in accreta management mostly was hysterectomy to override bleeding complication along the delivery. From 20 cases, 16 caesarean sections were followed-up with hysterectomy. Four cases were with conservative management. From all the hysterectomy performed, four were complicated with bladder injury. The mean intraoperative bleeding was 600 - 5500 cc of blood, while the mean of post-operative transfusion was 1000 -3000 cc. There were 2 maternal deaths in this study. Thirteen patients were admitted to the ICU after the procedure.
Conclusion: Accreta increases morbidity due to massive bleeding. It is important to have algorithm for managing abnormal implantation of the placenta. Our cases revealed no significant results of maternal outcome between conservative surgery and conventional hysterectomy in managing accreta cases in Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Arias F, Bhide A, Arulkumaran S, et al. Arias' Practical Guide to High-Risk Pregnancy and Delivery. A South Asian perspective. Chapter 10. 5th edition. Elsevier India; 2019. p. 158.
Soyer P, Morel O, Fargeaudou Y, et al. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta. Eur J Radiol. 2011;80(3):729-35. doi: 10.1016/j.ejrad.2010.07.018. Epub 2010 Aug 12. PMID: 20708361.
Grace Tan SE, Jobling TW, Wallace EM, et al. Surgical management of placenta accreta: a 10-year experience. Acta Obstet Gynecol Scand. 2013;92(4):445-50. doi: 10.1111/aogs.12075. Epub 2013 Jan 24. PMID: 23311505.
Fitzpatrick KE, Sellers S, Spark P, et al. The management and outcomes of placenta accrete, increta and percreta in the UK: a population-based descriptive study. BJOG 2014;121:62–71.
Wortman AC, Alexander JM. Placenta accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2013;40(1):137-54. doi: 10.1016/j.ogc.2012. 12.002. PMID: 23466142.
Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219(2):193.e1-193.e9. doi: 10.1016/j.ajog.2018.04.049. Epub 2018 May 5. PMID: 29733839.
Duzyj CM, Cooper A, Mhatre M, et al. Placenta accreta: A spectrum of predictable risk, diagnosis, and morbidity. Am J Perinatol. 2019;36(10):1031-1038. doi: 10.1055/s-0038-1676111. Epub 2018 Nov 30. PMID: 30500963.
Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011;90(10):1140-6. doi: 10.1111/ j.1600-0412.2011.01147.x. Epub 2011 May 25. PMID: 21488840.
Erfani H, Fox KA, Clark SL, et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019;221(4):337.e1-337.e5. doi: 10.1016/j.ajog. 2019.05.035. Epub 2019 Jun 4. PMID: 31173748.
Shamshirsaz AA, Fox KA, Erfani H, Clark SL, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):612.e1-612.e5. doi: 10.1016/ j.ajog.2017.02.016. Epub 2017 Feb 16. PMID: 28213059.
Durukan H, Durukan ÖB, Yazıcı FG. Planned versus urgent deliveries in placenta previa: maternal, surgical and neonatal results. Arch Gynecol Obstet. 2019;300(6):1541-1549. doi: 10.1007/s00404-019-05349-9. Epub 2019 Oct 26. PMID: 31655886.
Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27-36. doi: 10.1016/j.ajog.2017.02.050. Epub 2017 Mar 6. PMID: 28268196.
Peng X, Chen D, Xu J, et al. Parallel transverse uterine incisions, a novel approach for managing heavy hemorrhage and preserving the uterus: A retrospective cohort study for patients with anterior placenta previa and accreta. Medicine (Baltimore). 2019;98(44):e17742. doi: 10.1097/MD.00000000 00017742. PMID: 31689824; PMCID: PMC694 6211.
Matsubara S, Takahashi H, Takei Y, Imai Y. Methotrexate for placenta accreta spectrum disorders: Is it needed? J Clin Pharm Ther. 2020 Apr;45(2):399-400. doi: 10.1111/jcpt.13120. Epub 2020 Feb 5. PMID: 32023348.
Lin K, Qin J, Xu K, et al. Methotrexate management for placenta accreta: a prospective study. Arch Gynecol Obstet. 2015;291(6):1259-64. doi: 10.1007/s00404-014-3573-1. Epub 2014 Dec 11. PMID: 25501835.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
